Medicine and Dentistry
Complementary Therapy
100%
Arabinoxylan
100%
Cancer Therapy
100%
Randomized Controlled Trial
60%
Immune System
40%
Immunomodulating Agent
40%
Malignant Neoplasm
40%
Neoplasm
20%
In Vitro
20%
Clinical Study
20%
Adverse Event
20%
Radiation Therapy
20%
Recurrent Disease
20%
Tumor Progression
20%
Survival Rate
20%
Side Effect
20%
Intervention Study
20%
Drug Toxicity
20%
Carcinogen
20%
Base
20%
Clinical Trial
20%
Chemotherapy
20%
Natural Killer Cell
20%
Drug Resistance
20%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Arabinoxylan
100%
Randomized Controlled Trial
42%
Immunomodulating Agent
28%
Clinical Study
14%
Intervention Study
14%
Chemotherapy
14%
Clinical Trial
14%
Adverse Event
14%
Recurrent Disease
14%
Tumor Growth
14%
Survival Rate
14%
Side Effect
14%
Drug Toxicity
14%
Carcinogen
14%
Drug Resistance
14%
Neoplasm
14%
Base
14%
Keyphrases
Reduced Side Effects
10%
Prevent Recurrence
10%
Pre-post Intervention Study
10%